Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The firm has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The firm conducts its businesses within domestic and overseas markets.
Quelle est la performance du prix de l'action ZLAB ?
Le prix actuel de ZLAB est de $0, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Zai Lab Ltd ?
Zai Lab Ltd appartient à l'industrie Biotechnology et le secteur est Health Care
Quel est la capitalisation boursière de Zai Lab Ltd ?
La capitalisation boursière actuelle de Zai Lab Ltd est de $NaN
Est-ce que Zai Lab Ltd est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 10 analystes ont établi des notations d'analystes pour Zai Lab Ltd, y compris 2 achat fort, 9 achat, 3 maintien, 0 vente et 2 vente forte